Abstract
Indolcarboxamides are a promising series of anti-tubercular agents, which target Mycobacterium tuberculosis MmpL3, the exporter of trehalose monomycolate, a key cell-wall component. We determined the kill kinetics of the lead indolcarboxamide NITD-349 and determined that while kill was rapid against low-density cultures, bactericidal activity was inoculum-dependent. A combination of NITD-349 with isoniazid (which inhibits mycolate synthesis) had an increased kill rate; this combination prevented the appearance of resistant mutants, even at higher inocula.
| Original language | English |
|---|---|
| Article number | 001345 |
| Journal | Microbiology (United Kingdom) |
| Volume | 169 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 19 Jun 2023 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- anti-tubercular
- bactericidal activity
- cell-wall inhibitor
- tuberculosis drug discovery
Fingerprint
Dive into the research topics of 'Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver